Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Degradation Of Synthetic Salmon Calcitonin In Aqueous Solution

K. Lee, Y. J. Lee, Hyun Myo Song, C. J. Chun, P. D. Luca
Published 2004 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1016/0168-3659(91)90059-M
In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres
K. C. Lee (1991)
10.1093/CHROMSCI/29.4.136
Influence of the mobile phase on salmon calcitonin analysis by reversed-phase liquid chromatography.
I. H. Lee (1991)
10.1016/0003-2697(87)90291-0
Evidence for isoaspartyl1 (deamidated) forms of mouse epidermal growth factor
R. Diaugustine (1987)
10.1016/0378-5173(91)90184-P
Peptide and protein drugs: I. Therapeutic applications, absorption and parenteral administration
X. Zhou (1991)
10.1023/A:1015999012852
Chemical Pathways of Peptide Degradation. III. Effect of Primary Sequence on the Pathways of Deamidation of Asparaginyl Residues in Hexapeptides
Kamlesh Patel (2004)
10.1016/0378-5173(86)90221-8
Degradation of the LH-RH analog nafarelin acetate in aqueous solution
D. Johnson (1986)
10.1023/A:1015981704133
Stability of Gonadorelin and Triptorelin in Aqueous Solution
Volker J. Helm (2004)
10.1023/A:1015929109894
Stability of Protein Pharmaceuticals
M. Manning (2004)
10.1016/0378-5173(91)90160-P
Stability of the synthetic pentapeptide thymopentin in aqueous solution: Effect of pH and buffer on degradation
Volker J. Helm (1991)
10.1016/s0021-9258(19)75855-4
Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.
T. Geiger (1987)
10.1016/S0021-9673(00)94796-4
Correlation of calcitonin structure with chromatographic retention in high-performance liquid chromatography.
M. L. Heinitz (1988)
10.1677/JOE.0.0480181
INACTIVATION AND DEGRADATION OF PORCINE CALCITONIN BY RAT LIVER, AND RELATIVE STABILITY OF SALMON CALCITONIN
M. D. Luise (1970)
10.1210/ENDO-92-4-1102
A study of the stability of calcitonin biological activity.
F. Newsome (1973)
10.1023/A:1015862026539
Chemical Pathways of Peptide Degradation. I. Deamidation of Adrenocorticotropic Hormone
N. P. Bhatt (2004)
10.1002/HLCA.19680510731
Menschliches Calcitonin I. Isolierung und Charakterisierung
B. Riniker (1968)
10.1016/0026-0495(77)90030-0
Degradation of human calcitonin in human plasma
S. Baylin (1977)
10.1016/0300-9629(90)90083-5
The Calcitonins: Physiology and Pharmacology
M. Azria (1989)



This paper is referenced by
10.1007/S00216-003-2298-Y
Analytical procedures for quantification of peptides in pharmaceutical research by liquid chromatography–mass spectrometry
H. John (2004)
10.1002/9783527631360.CH7
Drug Delivery Through Skin: Overcoming the Ultimate Biological Membrane
D. Stamatialis (2008)
10.1016/j.jconrel.2016.07.047
Coated minispheres of salmon calcitonin target rat intestinal regions to achieve systemic bioavailability: Comparison between intestinal instillation and oral gavage.
T. Aguirre (2016)
10.1080/02652040010000334
Characterization of calcitonin-containing liposome formulations for intranasal delivery
S. L. Law, C. L. Shih (2001)
10.1016/J.TRAC.2011.01.013
Data analysis in stability studies of biopharmaceutical drugs with isothermal and non-isothermal assays
A. Oliva (2011)
10.1023/A:1022250809235
Structural Studies of EDTA-Induced Fibrillation of Salmon Calcitonin
Stefan Seyferth (2004)
10.1081/LPR-120026392
Stability of Desmopressin Loaded in Liposomes
S. Law (2003)
10.1201/9781420039832.CH3
Stability of Therapeutic Peptides and Proteins
A. Banga (2005)
10.1111/j.2042-7158.2004.tb02573.x
Preformulation stability of Spantide II, a promising topical anti‐inflammatory agent for the treatment of psoriasis and contact dermatitis
L. Kikwai (2004)
10.1023/A:1018955031042
Is Stability Prediction Possible for Protein Drugs? Denaturation Kinetics of β- Galactosidase in Solution
S. Yoshioka (2004)
10.1007/BF02830562
Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres
B. Dani (2008)
10.1016/j.ejps.2012.05.016
Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles.
M. Yang (2012)
10.1016/S1570-0232(02)00316-1
Simple liquid chromatography-electrospray ionization mass spectrometry method for the routine determination of salmon calcitonin in serum.
Keon-Hyoung Song (2002)
10.1023/A:1018925209080
Inhibition of Succinimide Formation in Aqueous Zn-rHirudin Suspensions1
U. Gietz (2004)
10.1007/s11095-013-1237-7
Synthesis, Characterization and Biodistribution Studies of 125I-Radioiodinated di-PEGylated Bone Targeting Salmon Calcitonin Analogue in Healthy Rats
Y. Yang (2013)
10.1080/1061186042000223644
Pulmonary Absorption Enhancement of Salmon Calcitonin
T. Mahesh Kumar (2004)
10.1016/j.jpba.2010.06.028
Quality analysis of salmon calcitonin in a polymeric bioadhesive pharmaceutical formulation: sample preparation optimization by DOE.
Matthias D'Hondt (2010)
10.1016/j.ijpharm.2016.12.051
Building parity between brand and generic peptide products: Regulatory and scientific considerations for quality of synthetic peptides.
L. Wu (2017)
10.1016/S0166-3542(01)00131-0
Comparative effects of stabilizing additives on the rates of heat inactivation of recombinant human interferon alpha-2b in solution.
H. K. Sebeka (2001)
Biodegradable multiblock copolymers for drug delivery applications
R. V. Dijkhuizen-Radersma (2004)
10.1002/JPS.10557
Protection of salmon calcitonin breakdown with serine proteases by various ovomucoid species for oral drug delivery.
R. Shah (2004)
10.1080/713840326
Stability of a Transdermal Salmon Calcitonin Formulation
Shu-Lun Chang (2003)
10.1081/DDC-120025459
Degradation Kinetics of Somatostatin in Aqueous Solution
J. Herrmann (2003)
10.1023/A:1018861616465
Isolation, Characterization, and Stability of Positional Isomers of Mono-PEGylated Salmon Calcitonins
K. Lee (2004)
10.3934/BIOPHY.2015.4.695
Salmon calcitonin: conformational changes and stabilizer effects
S. Lin (2015)
10.1023/A:1018945727640
Acid-Catalyzed Peptide Bond Hydrolysis of Recombinant Human Interleukin 11
R. Kenley (2004)
10.1023/A:1016203731682
Chemical Pathways of Degradation of the Bradykinin Analog, RMP-7
J. A. Straub (2004)
10.1016/j.ejpb.2011.05.010
Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation.
Dongho Oh (2011)
Encapsulation of fluorogenic probes and pharmacologically active molecules into nanoparticles for enhancing cellular uptake
Główka Eliza (2009)
10.1016/j.ijpharm.2011.11.046
Delivery of salmon calcitonin using a microneedle patch.
C. Taş (2012)
10.1016/j.ejps.2012.02.024
Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation.
M. Yang (2012)
10.1023/A:1016278902839
Adsorption of Salmon Calcitonin to PLGA Microspheres
S. Çalış (2004)
See more
Semantic Scholar Logo Some data provided by SemanticScholar